trial · primary record
Tobemstomig
Breast Cancer
| Phase | Phase 2 |
|---|---|
| Status | COMPLETED |
| Sponsor | Unknown |
| Enrolment | 83 |
| Primary completion | 2026-10-15 |
| Primary endpoint | Progression-Free Survival (PFS) |
| Registry ID | NCT05852691 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:45:58.151Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05852691
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.